Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T14:18:46.310Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of New Chemotherapeutic Agents in Acute and Chronic Myeloid Leukemia

Published online by Cambridge University Press:  01 August 2014

N. Quattrin  and
E. Dini
N. Quattrin
Affiliation:
Reparto di Ematologia degli Ospedali Riuniti di Napoli
E. Dini
Affiliation:
Reparto di Ematologia degli Ospedali Riuniti di Napoli

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Our experience in the Imuran treatment of acute leukemia is rather scarce. Indeed because of the difficulty to get this drug, we could use it in 6 cases only. These 6 cases belonged to the following forms: 3 to the stem cells type, 1 to the myelomonocytic type, 1 to the histiomonocytic ungranulated type, 1 to the promyelocytic type (acute terminal crisis of chronic myeloid leukemia). All these patients had been already treated with other antiblastics.

Positive results we had just in 2 cases, precisely in a case of stem cells leukemia and in the last case above mentioned. Similar results in acute relapsing phase of chronic myeloid leukemia obtained Eridani et al. (1965). Where we applied strong doses (mg 30c of Imuran daily for 10 days), following the advice of Storti and Traldi (1965), and thus obtained a full three months remission (Fig. 1).

According to this modest experience of ours Azathioprine is a drug that does not present clear advantages on 6-Mercaptopurin.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 17 , Issue 1 , January 1968 , pp. 255 - 257
Copyright
Copyright © The International Society for Twin Studies 1968

References

Storti, E., Traldi, A. (1965). Grave atelectasia polmonare da compressione (quale esordio di leucemia linfatica acuta) trattata con successo con solo 6 [(iemetil-4-nitro-5-imidazolyl) tio] purina Min. Med., 56: 3576.Google Scholar
Eridani, S., et al. (1965). Clinical trial of Azathioprine, a new analeukaemic compound. Panmin. Med., 275.Google Scholar
Gericke, D. (1964). Erfahrungen mit neueren Aetyleniminen. Neoplasma, 11: 329.Google Scholar
Ehrhart, H. (1962). Langzeit-Chemotherapie chronisch-myeloischer Leukaemien mit Myrelan und C 69. Klin. Wschr., 40: 622,Google Scholar
Grignani, F. et al. (1965). Rilievi clinico-statistici sulle emopatie maligne osservate nella Clinica Medica di Perugia nel triennio 1962-64. Rass. Clin. Ter. Sci. Affini, 64: 137.Google Scholar